These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11435843)

  • 1. A crossover randomized trial of transcutaneous electrical nerve stimulation and oxybutynin in patients with detrusor instability.
    Soomro NA; Khadra MH; Robson W; Neal DE
    J Urol; 2001 Jul; 166(1):146-9. PubMed ID: 11435843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder.
    Amarenco G; Ismael SS; Even-Schneider A; Raibaut P; Demaille-Wlodyka S; Parratte B; Kerdraon J
    J Urol; 2003 Jun; 169(6):2210-5. PubMed ID: 12771752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability.
    Hasan ST; Robson WA; Pridie AK; Neal DE
    J Urol; 1996 Jun; 155(6):2005-11. PubMed ID: 8618309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
    Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
    J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of electric stimulation and oxybutynin chloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial.
    Wang AC; Chih SY; Chen MC
    Urology; 2006 Nov; 68(5):999-1004. PubMed ID: 17113893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity.
    Salvatore S; Khullar V; Cardozo L; Milani R; Athanasiou S; Kelleher C
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):237-41. PubMed ID: 15808387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.
    Gacci M; Del Popolo G; Macchiarella A; Celso M; Vittori G; Lapini A; Serni S; Sandner P; Maggi M; Carini M
    J Urol; 2007 Nov; 178(5):2040-3; discussion 2044. PubMed ID: 17869296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
    Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
    J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.
    Dmochowski RR; Davila GW; Zinner NR; Gittelman MC; Saltzstein DR; Lyttle S; Sanders SW;
    J Urol; 2002 Aug; 168(2):580-6. PubMed ID: 12131314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic effects of intrarectal administration of oxybutynin].
    Radziszewski P; Borkowski A
    Wiad Lek; 2002; 55(11-12):691-8. PubMed ID: 12715351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous electrical nerve stimulation for refractory daytime urinary urge incontinence.
    Hagstroem S; Mahler B; Madsen B; Djurhuus JC; Rittig S
    J Urol; 2009 Oct; 182(4 Suppl):2072-8. PubMed ID: 19695629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation.
    Karademir K; Baykal K; Sen B; Senkul T; Iseri C; Erden D
    Scand J Urol Nephrol; 2005; 39(3):230-3. PubMed ID: 16118096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transcutaneous electrical stimulation for the control of frequency and urge incontinence].
    Nakamura M; Sakurai T; Tsujimoto Y; Tada Y
    Hinyokika Kiyo; 1983 Sep; 29(9):1053-9. PubMed ID: 6610298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcutaneous Electrical Nerve Stimulation Combined with Oxybutynin is Superior to Monotherapy in Children with Urge Incontinence: A Randomized, Placebo Controlled Study.
    Borch L; Hagstroem S; Kamperis K; Siggaard CV; Rittig S
    J Urol; 2017 Aug; 198(2):430-435. PubMed ID: 28327453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of oxybutynin on urinary symptoms in children with Williams-Beuren syndrome.
    Sammour ZM; Gomes CM; de Bessa J; Pinheiro MS; Kim CA; Honjo RS; Trigo-Rocha FE; Bruschini H; Srougi M
    J Urol; 2012 Jul; 188(1):253-7. PubMed ID: 22595063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulation.
    van der Pal F; van Balken MR; Heesakkers JP; Debruyne FM; Kiemeney LA; Bemelmans BL
    BJU Int; 2006 Jan; 97(1):113-6. PubMed ID: 16336339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of long-term administration of oxybutynin hydrochloride (KL007) for the treatment of neurogenic bladder and unstable bladder].
    Sonoda T; Sakurai T; Yamada K; Mizutani S; Tsujimoto Y; Ogawa T
    Hinyokika Kiyo; 1989 Jan; 35(1):167-78. PubMed ID: 2658513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
    Giannitsas K; Perimenis P; Athanasopoulos A; Gyftopoulos K; Nikiforidis G; Barbalias G
    Eur Urol; 2004 Dec; 46(6):776-82; discussion 782-3. PubMed ID: 15548447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open-label, dose-titration study.
    Kennelly MJ; Lemack GE; Foote JE; Trop CS
    Urology; 2009 Oct; 74(4):741-5. PubMed ID: 19628264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.